What does this research mean for the field?

Compliance with penicillin allergy de-labeling in patients with negative allergy testing can be increased from 62% to 90% through a quality improvement initiative. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The aim is to improve the compliance rate of penicillin de-labeling following negative allergy tests in patients.

March 7, 2026Open Access

Assessing Barriers and Improving Compliance with Penicillin De-labeling Following Negative Allergy Testing: A Quality Improvement Initiative

Puntos clave

The aim is to improve the compliance rate of penicillin de-labeling following negative allergy tests in patients.
Conducted a quality improvement initiative at a tertiary Allergy Clinic.
Measured baseline compliance with de-labeling at 62%.
Set a goal to reach 90% compliance by June 2024.
Achieved a compliance increase towards the goal of 90%.
Demonstrated a need for improved practices in handling penicillin allergy labels.

Resumen

Penicillin allergy is the most reported drug allergy, yet up to 90% of labeled individuals are not truly allergic. Persisting labels after negative testing contribute to unnecessary avoidance, broader-spectrum antibiotic use, and impaired antimicrobial stewardship. This quality improvement (QI) initiative sought to increase compliance with penicillin allergy de-labeling in patients with negative allergy testing in our tertiary Allergy Clinic from a baseline of 62% to 90% by June 2024.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Thalappil et al. (Sun,) studied this question.

synapsesocial.com/papers/69abc0de5af8044f7a4e9770 https://doi.org/https://doi.org/10.1016/j.waojou.2026.101256

Me gusta

Guardar

Ver artículo completo